Studies on the mechanism of inhibition of bacterial ribonuclease P by aminoglycoside derivatives

Nucleic Acids Research

Volumn 36, Issue 2, 2008, Pages 697-704

  Kawamoto, Steven A ^a   Sudhahar, Christopher G ^a   Hatfield, Cynthia L ^a   Sun, Jing ^a   Behrman, Edward J ^a   Gopalan, Venkat ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ARGININE CONJUGATE; AMINOGLYCOSIDE DERIVATIVE; ARCHAEAL PROTEIN; ARGININE; BACTERIAL ENZYME; ENZYME INHIBITOR; FRAMYCETIN; HOLOENZYME; MAGNESIUM ION; RIBONUCLEASE P; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG MECHANISM; ENZYME INHIBITION; ENZYME SYNTHESIS; INHIBITION KINETICS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ARCHAEA; ARGININE; BASE SEQUENCE; ESCHERICHIA COLI PROTEINS; FRAMYCETIN; GUANIDINES; LYSINE; MAGNESIUM; MOLECULAR SEQUENCE DATA; RIBONUCLEASE P; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

ARCHAEA; BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 39149107446     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm1088     Document Type: Article

References (50)

1. Gallego,J. and Varani,G. (2001) Targeting RNA with small-molecule drugs: Therapeutic promise and chemical challenges. Acc. Chem.Res., 34 836-843.
2. Hermann,T. (2003) Chemical and functional diversity of small molecule ligands for RNA. Biopolymers, 70, 4-48.
3. Hermann,T. and Tor,Y. (2005) RNA as target for smaff molecule therapeutics. Expert Opin. Ther. Patents, 15, 49-62.
4. Silva,J.G. and Carvalho,I. (2007) New insights into aminoglycoside antibiotics and derivatives. Curr. Med. Chem., 14, 1101-1119.
5. Hall,T.A. and Brown,J.W. (2001) The ribonuclease P family. Meth. Enzymol., 341, 56-77.
6. Evans,.D., Marquez,S.M. and Pace,N.R. (2006) RNase P: Interface of the RNA and protein worlds. Trends Biochem. Sci., 31, 333-341.
7. Gopalan,V. and Altman,S. (2006) Ribonuclease P: Structure and catalysis. In Gesteland,R.F., Cech,T. and Atkins,J.F. (eds), The RNA World. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NYChapter 6.1 (online only at http://rna.cshl.edu).
8. Walker,S.C. and Engelke,D.R. (2006) Ribonuclease P: The evolution of an ancient RNA enzyme. Crit. Rev. Biochem. Mol. Biol., 41, 77-102.
9. Eder,P.S., Hatfield,C., Vioque,A. and Gopalan,V. (2003) Bacterial RNase P as a potential target for novel anti-infectives. Curr. Opin. Invest. Drugs., 4, 937-943.
10. Willkomm,D.K., Gruegelsiepe,H., Goudinalds,O., Kretschmer-Kazemi Far,R., Bald,R., Erdmann,V.A. and Hartmann,R.K. (2003) Evaluation of bacterial RNase P as a drug target. ChemBioChem., 4, 1041-1048.
11. Dahlberg,A.E., Horodyski,F. and Keller,P. (1978) Interaction of neomycin with ribosomes and ribosornal ribonucleic acid. Antimicrob. Agents Chemother., 13, 331-339.
12. Moazed,D. and Noller,H.F. (1987) Interactions of antibiotics with functional sites in 16S ribosomal RNA. Nature, 327, 389-394.
13. Tor,Y. (2006) The ribosomal A-site as an inspiration for the design of RNA binders. Biochimie, 88, 1045-1051.
14. Zapp,M.L., Stern,S. and Green,M.R. (1993) Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell, 74, 969-978.
15. von Ahsen,U., Davies,J. and Schroeder,R. (1991) Antibiotic inhibition of group I ribozyme function. Nature, 353, 368-370.
16. Rogers,J., Chang,A.H., von Ahsen,U., Schroeder,R. and Davics,J. (1996) Inhibition of the self-cleaving reaction of the human Hepatitis delta virus ribozyme by antibiotics. J. Mol. Biol., 259, 916-925.
17. Mikkelsen,N.E., Brännvall,M., Virtanen,A. and Kirsebom,L. (1999) Inhibition of RNase P RNA cleavage by AGs. Proc. Natl Acad. Sci. USA 96, 6155-6160.
18. Hermann,T. and Westhof,E. (1998) Aminoglycoside binding to the hammerhead ribozyme: A general model for the interaction of cationic antibiotics with RNA. J. Mol. Biol., 276, 903-912.
19. Tor,Y., Hermann,T. and Westhof,E. (1998) Deciphering RNA recognition: aminoglycoside binding to the hammerhead ribozyme. Chem. Biol., 5, R277-283.
20. Vicens,Q. and Westhof,E. (2003) Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: An analysis of X-ray crystal structures. Biopolymers, 70, 42-57.
21. Leudtke,N.W., Baker,T.J., Goodman,M. and Tor,Y. (2000) Guanidinoglycosides: A novel family of RNA ligands. J. Am. Chem. Soc. 122, 12035-12036.
22. Tan,R. and Frankel,A.D. (1995) Structural variety of arginine-rich RNA binding peptides. Proc. Natl Acad. Sci. USA, 92, 5282-5286.
23. Puglisi,J.D., Chen,L., Blanchard,S. and Frankel,A.D. (1995) Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex. Science, 270, 1200-1203.
24. Litovchick,A., Evdokimov,A.G. and Lapidot,A. (2000) Arginine-aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro. Biochemistry, 39, 2838-2852.
25. Litovchick,A., Lapidot,A., Eisenstein,M., Kalinkovich,A. and Borkow,G. (2001) Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities. Biochemistry, 40, 15612-15623.
26. Eubank,T.D., Biswas,R., Jovanovic,M., Litovchick,A., Lapidot,A. and Gopalan,V. (2002) Inhibition of bacterial RNase P by aminoglycoside-arginine conjugates. FEBS Lett., 511, 107-112.
27. Kawamato,S.A. (2004) Elucidating structure-activity relationships and the mechanism of inhibition of bacterial RNase P by aminoglycoside derivatives. B.S. (Honors) Thesis, The Ohio State University, Columbus, OH, USA.
28. Vioque,A., Arnez,J. and Altman,S. (1988) Protein-RNA interactions in the RNase P holoenzyme from Escherichia coli. J. Mol. Biol., 202 835-848.
29. Boomershine,W.P., McElroy,C.A., Tsai,H.Y., Wilson,R.C., Gopalan,V. and Foster,M.P. (2003) Structure of Mth11/Mth Rpp29, an essential protein subunit of archaeal and eukaryotic RNase P. Proc. Natl Acad. Sci. USA 100, 15398-15403.
30. Tsai,H.Y., Pulukkunat,D.K., Woznick,W. and Gopalan,V. (2006) Functional reconstitution and characterization of Pyrococcus furiosus RNase P. Proc. Natl Acad. Sci. USA, 103, 16147-16152.
31. Zhu,Y., Pulukkunat,D.K. and Li,Y. (2007) Deciphering RNA structural diversity and systematic phylogeny from microbial metagenomes. Nucleic Acids Res., 35, 2283-2294.
32. Zahler,N.H., Christian,E.I., and Harris,M.E. (2003) Recognition of the 5′ leader of pre-tRNA substrates by the active site of ribonuclease P. RNA, 9, 734-745.
33. Baker,T.J., Tomioka,M. and Goodman,M. (2000) Preparation and use of N,N′-di-Boc-N″-triflylguanidine. Org. Syn., 78, 91-98.
34. Baker,T.J., Luedtke,N.W., Tor,Y. and Goodman,M. (2000) Synthesis and anti-HIV activity of guanidinoglycosides. J. Org. Chem., 65, 9054-9058.
35. Hui,Y., Ptak,R., Paulman,R., Pallansch,M. and Chang,C.W.T. (2002) Syntheis of novel guanidine incorporated AGs, guanidinopyranamycins. Tetrahedron Lett., 43, 9255-9257.
36. Jovanovic,M., Sanchez,R., Altman,S. and Gopalan,V. (2002) Elucidation of stracture-function relationships in the protein subunit of bacterial RNase P using a genetic complementation approach. Nucleic Acids Res. 22, 4087-4094.
37. Hatfield,C.L. (2004) Elucidating the mechanism of inhibition of bacterial RNase P by aminoglycoside derivatives. M.S. Thesis, Department of Biochemistry, The Ohio State University, Columbus, OH, USA.
38. Mikkelsen,N.E., Johansson,K., Virtanen,A. and Kirsebom,L.A. (2001) Aminoglycoside binding displaces a divalent metal ion in a tRNA-neomycin B complex. Nature Struct. Biol., 8, 510-514.
39. Hoch,I., Berens,C., Westhof,E. and Schroeder,R. (1998) Antibiotic inhibition of RNA catalysis: Neomycin B binds to the catalytic core of the td group I intron displacing essential metal ions. J. Mol. Biol., 282, 557-569.
40. Harris,J.K., Haas,E.S., Williams,D.A. and Brown,J.W. (2001) New insights into RNase P RNA structure from comparative analysis of the archaeal RNA. RNA, 7, 220-232.
41. Arya,D., Xue,L. and Willis,B. (2003) Aminoglycoside (neomycin) preference is for A-form nucleic acids, not just RNA: Results from a competition dialysis study. J. Am. Chem. Soc., 125, 10148-10149.
42. Earnshaw,D.J. and Gait,M.J. (1998) Hairpin ribozyme cleavage catalyzed by aminoglycoside antibiotics and the polyamine spermine in the absence of metal ions. Nucleic Acids Res., 26, 5561-5571.
43. Thuresson,A.-C., Kirsebom,L.A. and Virtanen,A. (2007) Inhibition of polyA polymerase by AGs. Biochimie, 89, 1221-1227.
44. Kazakov,S. and Altman,S. (1991) Site-specific cleavage by metal ion cofactors and inhibitors of M1 RNA, the catalytic subunit of RNase P from Escherichia coli. Proc. Natl Acad. Sci. USA, 88, 9193-9197.
45. Kirsebom,L.A. (2007) RNase P RNA mediated cleavage: Substrate recognition and catalysis. Biochimie, 89, 1183-1194.
46. Torres-Larios,A., Swinger,K.K., Krasilnikov,A.S., Pan,T. and Mondragon,A. (2005) Crystal structure of the RNA component of bacterial ribonuclease P. Nature, 437, 584-587.
47. Kazantsev,A.V., Krivenko,A.A., Harrington,D.J., Holbrook,S.R., Adams,P.D. and Pace,N.R. (2005) Crystal structure of a bacterial ribonuclease P RNA. Proc Natl Acad. Sci. USA, 102, 13392-13397.
48. Carriere,M., Vijayabaskar,V., Applefield,D., Harvey,I., Garneau,P., Lorsch,J., Lapidot,A. and Pelletier,J. (2002) Inhibition of protein synthesis by aminoglycoside-arginine conjugates. RNA, 8, 1267-1279.
49. Christian,E.L., Zahler,N.H., Kaye,N.M. and Harris,M.E. (2002) Analysis of substrate recognition by the ribonucleoprotein endonuclease RNase P. Methods, 28, 307-322.
50. Brown,J.W. (1999) The ribonuclease P database. Nucleic Acids Res., 27, 314.